课题基金 / 基金详情

COX-2 blockade immunologically suppresses brain metastasis of lung cancer

COX-2 blockade immunologically suppresses brain metastasis of lung cancer
COX-2阻断免疫学抑制肺癌脑转移
批准号:
24700998
负责人:
FUJITA Mitsugu
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

FUJITA Mitsugu的其他基金

相似基金

相关文献

中文摘要
翻译
经常使用非甾体抗炎药与降低人类癌症风险之间的联系已经得到证实。非甾体抗炎药的功能是作为COX-2抑制剂,阻止PGE2的产生,PGE2在癌症宿主中诱导MDSCs。因此,我们假设COX-2阻断可以通过抑制MDSC的发育及其趋化因子介导的肿瘤微环境(TME)积累来抑制癌症的脑转移。在小鼠和人类脑转移病例中,COX-2和CCL2(一种主要吸引MDSCs的趋化因子)在肿瘤组织中的表达水平均高于外周或正常脑。同时,在肿瘤组织中观察到高水平的MDSCs浸润。在使用LL/2小鼠肺癌细胞系的小鼠脑肿瘤模型中,NSAIDs治疗通过抑制MDSCs抑制脑转移的形成。我们的研究结果表明,COX-2通路通过MDSCs的发育和积累促进肺癌脑转移。
英文摘要
Associations between the regular use of NSAIDs and reduced cancer risks in human have been shonw. NSAIDs function as COX-2 inhibitors that prevent the production of PGE2, which induces MDSCs in cancer-bearing hosts. We thus hypothesized that COX-2 blockade would suppress brain metastasis of cancers by inhibiting MDSC development and their chemokine-mediated accumulation in the tumor microenvironment (TME). In both mouse and human brain metastasis cases, the expression levels of COX-2 and CCL2, a chemokine primarily attracting MDSCs, were increased in the tumor tissues compared with the periphery or normal brain. Concomitantly, the infiltration of MDSCs was observed at high levels in the tumor tissues. In the mouse brain tumor models using LL/2 murine lung cancer cell line, treatment with NSAIDs inhibited brain metastasis formation with the suppression of MDSCs. Our findings show that the COX-2 pathway promotes brain metastases of lung cancers by development and accumulation of MDSCs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4161/onci.19964
发表时间: 2012-07-01
期刊: Oncoimmunology
影响因子: 7.2
作者: [Kohanbash G, Ishikawa E, Fujita M, Ikeura M, McKaveney K, Zhu J, Sakaki M, Sarkar SN, Okada H]
通讯作者: Okada H
非小細胞肺癌の転移性脳腫瘍に対する治療戦略- driver oncogeneを標的とした個別化治療への展望
非小细胞肺癌转移性脑肿瘤的治疗策略——针对驱动癌基因的个性化治疗前景
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Okuda T, Kanada Y, Yoshioka H, Tasaki T, Fujita M, Nakagawa K, Kato A]
通讯作者: Kato A
Prophylactic COX-2 inhibition suppresses brain metastasis of lung cancer by inhibiting myeloid-derived suppressor cells.
预防性 COX-2 抑制通过抑制骨髓源性抑制细胞来抑制肺癌脑转移。
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [Fujita M, Miura R, Nakata S, Okuda T, Komohara Y, Kuzushima K, Kato A, Yo hie O.]
通讯作者: Yo hie O.
Efficacy of preoperative FDG-PET or malignant brain tumor
术前 FDG-PET 或恶性脑肿瘤的疗效
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Tasaki N, Okuda T, Yoshioka H, Takada H, Fujita M, Kato A]
通讯作者: Kato A
共 12 条
    Significance of B7 family expressed on macrophages relevant to radiation necrosis of brain
    • 批准号:
      18K09012
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      FUJITA Mitsugu
    • 依托单位:
    Impact of M2 macrophages on glioma-relevant radiation necrosis of the brain
    • 批准号:
      15K10348
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      FUJITA Mitsugu
    • 依托单位:
    海外基金